# Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL)

> **NCT02387697** · PHASE2,PHASE3 · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 28 (actual)

## Conditions studied

- Severe Tricuspid Regurgitation

## Interventions

- **DEVICE:** Edwards Sapien XT Valve

## Key facts

- **NCT ID:** NCT02387697
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Safety concerns
- **Last updated:** 2018-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02387697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02387697, "Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02387697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*